{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T18:00:19Z","timestamp":1795111219677,"version":"4.10.3"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.antiviral.2020.104711","type":"journal-article","created":{"date-parts":[[2020,1,12]],"date-time":"2020-01-12T09:23:14Z","timestamp":1578820994000},"page":"104711","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":121,"special_numbering":"C","title":["Advances in the genotypic diagnosis of cytomegalovirus antiviral drug resistance"],"prefix":"10.1016","volume":"176","author":[{"given":"Sunwen","family":"Chou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2020.104711_bib1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.antiviral.2019.06.004","article-title":"Persistent primary cytomegalovirus infection in a kidney transplant recipient: multi-drug resistant and compartmentalized infection leading to graft loss","volume":"168","author":"Andrei","year":"2019","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104711_bib2","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1128\/jvi.70.3.1390-1395.1996","volume":"70","author":"Baldanti","year":"1996","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104711_bib3","doi-asserted-by":"crossref","first-page":"10230","DOI":"10.1128\/JVI.00986-15","article-title":"Antagonistic relationship between human cytomegalovirus pUL27 and pUL97 activities during infection","volume":"89","author":"Bigley","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104711_bib4","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1128\/AAC.46.8.2365-2372.2002","article-title":"Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action","volume":"46","author":"Biron","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104711_bib5","doi-asserted-by":"crossref","first-page":"9077","DOI":"10.1128\/JVI.75.19.9077-9086.2001","article-title":"A novel nonnucleoside inhibitor specifically targets cytomegalovirus DNA maturation via the UL89 and UL56 gene products","volume":"75","author":"Buerger","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104711_bib6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/rmv.1873","article-title":"Human cytomegalovirus antiviral drug resistance in hematopoietic stem cell transplantation: current state of the art","volume":"26","author":"Campos","year":"2016","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.antiviral.2020.104711_bib7","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1177\/135965350801300504","article-title":"Putative functional domains of human cytomegalovirus pUL56 involved in dimerization and benzimidazole D-ribonucleoside activity","volume":"13","author":"Champier","year":"2008","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2020.104711_bib8","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1309533","article-title":"Letermovir for cytomegalovirus prophylaxis in hematopoietic-cell transplantation","volume":"370","author":"Chemaly","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2020.104711_bib9","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1093\/cid\/ciy696","article-title":"Definitions of resistant and refractory cytomegalovirus infection and disease in transplant recipients for use in clinical trials","volume":"68","author":"Chemaly","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104711_bib10","doi-asserted-by":"crossref","first-page":"17462","DOI":"10.1073\/pnas.1405981111","article-title":"Mechanism of ganciclovir-induced chain termination revealed by resistant viral polymerase mutants with reduced exonuclease activity","volume":"111","author":"Chen","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2020.104711_bib11","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1111\/ajt.15135","article-title":"Emergence of letermovir resistance in a lung transplant recipient with ganciclovir-resistant cytomegalovirus infection","volume":"18","author":"Cherrier","year":"2018","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.antiviral.2020.104711_bib12","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.antiviral.2009.10.004","article-title":"A new tool linking human cytomegalovirus drug resistance mutations to resistance phenotypes","volume":"85","author":"Chevillotte","year":"2010","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104711_bib13","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/infdis\/171.3.576","article-title":"Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistance","volume":"171","author":"Chou","year":"1995","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104711_bib14","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1128\/JVI.78.13.7124-7130.2004","article-title":"Mutations in the human cytomegalovirus UL27 gene that confer resistance to maribavir","volume":"78","author":"Chou","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104711_bib15","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1128\/AAC.49.7.2710-2715.2005","article-title":"Phenotyping of cytomegalovirus drug resistance mutations by using recombinant viruses incorporating a reporter gene","volume":"49","author":"Chou","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104711_bib16","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1128\/AAC.00207-06","article-title":"Effect of cell culture conditions on the anticytomegalovirus activity of maribavir","volume":"50","author":"Chou","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104711_bib17","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1128\/AAC.00736-07","article-title":"Growth and drug resistance phenotypes resulting from cytomegalovirus DNA polymerase region III mutations observed in clinical specimens","volume":"51","author":"Chou","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104711_bib18","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1086\/518514","article-title":"Cytomegalovirus UL97 kinase mutations that confer maribavir resistance","volume":"196","author":"Chou","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104711_bib19","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1128\/JVI.01787-07","article-title":"Accelerated evolution of maribavir resistance in a cytomegalovirus exonuclease domain II mutant","volume":"82","author":"Chou","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104711_bib20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1128\/AAC.01177-08","article-title":"Diverse cytomegalovirus UL27 mutations adapt to loss of viral UL97 kinase activity under maribavir","volume":"53","author":"Chou","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104711_bib21","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jcv.2011.01.004","article-title":"Phenotypic diversity of cytomegalovirus DNA polymerase gene variants observed after antiviral therapy","volume":"50","author":"Chou","year":"2011","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2020.104711_bib22","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1128\/AAC.01259-10","article-title":"Cytomegalovirus UL97 mutations affecting cyclopropavir and ganciclovir susceptibility","volume":"55","author":"Chou","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104711_bib23","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1128\/AAC.00511-13","article-title":"Cytomegalovirus UL97 kinase catalytic domain mutations that confer multi-drug resistance","volume":"57","author":"Chou","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104711_bib24","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1093\/infdis\/jit654","article-title":"Phenotypic evaluation of previously uncharacterized cytomegalovirus DNA polymerase sequence variants detected in a valganciclovir treatment trial","volume":"209","author":"Chou","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104711_bib25","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.1128\/AAC.03214-14","article-title":"Improved detection of emerging drug-resistant mutant cytomegalovirus subpopulations by deep sequencing","volume":"58","author":"Chou","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104711_bib26","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1128\/AAC.02544-13","article-title":"Cytomegalovirus mutants resistant to ganciclovir and cidofovir differ in susceptibilities to synguanol and its 6-ether and 6-thioether derivatives","volume":"58","author":"Chou","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104711_bib27","doi-asserted-by":"crossref","first-page":"6588","DOI":"10.1128\/AAC.01623-15","article-title":"Rapid in vitro evolution of human cytomegalovirus UL56 mutations that confer letermovir resistance","volume":"59","author":"Chou","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104711_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2017.10.019","article-title":"A third component of the human cytomegalovirus terminase complex is involved in letermovir resistance","volume":"148","author":"Chou","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104711_bib29","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01325-17","article-title":"Comparison of cytomegalovirus terminase gene mutations selected after exposure to three distinct inhibitor compounds","volume":"61","author":"Chou","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104711_bib30","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.antiviral.2016.12.003","article-title":"Foscarnet resistance mutations mapping to atypical domains of the cytomegalovirus DNA polymerase gene","volume":"138","author":"Chou","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104711_bib31","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1128\/JCM.00391-17","article-title":"Differentiated levels of ganciclovir resistance conferred by mutations at codons 591 to 603 of the cytomegalovirus UL97 kinase gene","volume":"55","author":"Chou","year":"2017","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2020.104711_bib32","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00922-18","article-title":"New locus of drug resistance in the human cytomegalovirus UL56 gene revealed by in vitro exposure to letermovir and ganciclovir","volume":"62","author":"Chou","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104711_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104616","article-title":"Novel UL97 drug resistance mutations identified at baseline in a clinical trial of maribavir for resistant or refractory cytomegalovirus infection","volume":"172","author":"Chou","year":"2019","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104711_bib34","doi-asserted-by":"crossref","first-page":"5927","DOI":"10.1128\/JVI.72.7.5927-5936.1998","article-title":"Characterization of drug resistance-associated mutations in the human cytomegalovirus DNA polymerase gene by using recombinant mutant viruses generated from overlapping DNA fragments","volume":"72","author":"Cihlar","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104711_bib35","article-title":"Letermovir resistance analysis in a clinical trial of cytomegalovirus prophylaxis for hematopoietic stem cell transplant recipients","author":"Douglas","year":"2019","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104711_bib36","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0928-0197(93)90012-T","article-title":"Antiviral susceptibility testing of cytomegalovirus: criteria for detecting resistance to antivirals","volume":"1","author":"Drew","year":"1993","journal-title":"Clin. Diagn. Virol."},{"key":"10.1016\/j.antiviral.2020.104711_bib37","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jcv.2006.07.010","article-title":"Maribavir sensitivity of cytomegalovirus isolates resistant to ganciclovir, cidofovir or foscarnet","volume":"37","author":"Drew","year":"2006","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2020.104711_bib38","doi-asserted-by":"crossref","first-page":"3216","DOI":"10.1128\/JCM.01275-13","article-title":"Novel method based on \"en passant\" mutagenesis coupled with a gaussia luciferase reporter assay for studying the combined effects of human cytomegalovirus mutations","volume":"51","author":"Drouot","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2020.104711_bib39","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1182\/blood.V96.9.3286","article-title":"Drug-resistant human cytomegalovirus infection in children after allogeneic stem cell transplantation may have different clinical outcomes","volume":"96","author":"Eckle","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.antiviral.2020.104711_bib40","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1056\/NEJM198902023200505","article-title":"Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients","volume":"320","author":"Erice","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2020.104711_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2016.04.002","article-title":"Identification of resistance-associated HCMV UL97- and UL54-mutations and a UL97-polymorphism with impact on phenotypic drug-resistance","volume":"131","author":"Fischer","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104711_bib42","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jcv.2016.04.017","article-title":"Contribution of next generation sequencing to early detection of cytomegalovirus UL97 emerging mutants and viral subpopulations analysis in kidney transplant recipients","volume":"80","author":"Garrigue","year":"2016","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2020.104711_bib43","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1128\/AAC.01794-13","article-title":"Geno- and phenotypic characterization of human cytomegalovirus mutants selected in vitro after letermovir (AIC246) exposure","volume":"58","author":"Goldner","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104711_bib44","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.antiviral.2015.01.006","article-title":"Phenotypic characterization of two naturally occurring human cytomegalovirus sequence polymorphisms located in a distinct region of ORF UL56 known to be involved in in vitro resistance to letermovir","volume":"116","author":"Goldner","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104711_bib45","article-title":"Characterization of the dynamics of human cytomegalovirus resistance to antiviral drugs by ultra-deep sequencing","volume":"173","author":"Guermouche","year":"2019","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104711_bib46","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1093\/infdis\/jix157","article-title":"Characterization of human cytomegalovirus genome diversity in immunocompromised hosts by whole-genome sequencing directly from clinical specimens","volume":"215","author":"Hage","year":"2017","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104711_bib47","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1086\/346240","article-title":"Ganciclovir-resistant cytomegalovirus disease after allogeneic stem cell transplantation: pitfalls of phenotypic diagnosis by in vitro selection of an UL97 mutant strain","volume":"187","author":"Hamprecht","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104711_bib48","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.3389\/fmicb.2016.01317","article-title":"Detection of low frequency multi-drug resistance and novel putative maribavir resistance in immunocompromised pediatric patients with cytomegalovirus","volume":"7","author":"Houldcroft","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.antiviral.2020.104711_bib49","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1126\/science.1152095","article-title":"Phosphorylation of retinoblastoma protein by viral protein with cyclin-dependent kinase function","volume":"320","author":"Hume","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.antiviral.2020.104711_bib50","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0002-9394(01)01161-8","article-title":"Longitudinal observations on mutations conferring ganciclovir resistance in patients with acquired immunodeficiency syndrome and cytomegalovirus retinitis","volume":"132","author":"Jabs","year":"2001","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.antiviral.2020.104711_bib51","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1128\/AAC.00571-11","article-title":"Cyclopropavir inhibits the normal function of the human cytomegalovirus UL97 kinase","volume":"55","author":"James","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104711_bib52","article-title":"De novo genotypic heterogeneity in the UL56 region in cytomegalovirus-infected tissues: implications for primary letermovir resistance","author":"Jo","year":"2019","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104711_bib53","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1186\/s12879-019-4016-1","article-title":"Fast breakthrough of resistant cytomegalovirus during secondary letermovir prophylaxis in a hematopoietic stem cell transplant recipient","volume":"19","author":"Jung","year":"2019","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104711_bib54","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/QCO.0000000000000607","article-title":"Resistant or refractory cytomegalovirus infections after hematopoietic cell transplantation: diagnosis and management","volume":"32","author":"Khawaja","year":"2019","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104711_bib55","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/tid.12241","article-title":"Cytomegalovirus antiviral resistance: characterization of results from clinical specimens","volume":"16","author":"Kleiboeker","year":"2014","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104711_bib56","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.antiviral.2013.10.011","article-title":"Resistance of human cytomegalovirus to ganciclovir\/valganciclovir: a comprehensive review of putative resistance pathways","volume":"101","author":"Komatsu","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104711_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2019.104549","article-title":"In-depth genomic analyses identified novel letermovir resistance-associated substitutions in the cytomegalovirus UL56 and UL89 gene products","volume":"169","author":"Komatsu","year":"2019","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104711_bib58","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1128\/AAC.01726-13","article-title":"Human cytomegalovirus UL97 kinase is involved in the mechanism of action of methylenecyclopropane analogs with 6-ether and -thioether substitutions","volume":"58","author":"Komazin-Meredith","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104711_bib59","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1081\/NCN-120023123","article-title":"Resistance of human cytomegalovirus to D- and L-ribosyl benzimidazoles as a tool to identify potential targets for antiviral drugs","volume":"22","author":"Komazin","year":"2003","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.antiviral.2020.104711_bib60","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/TP.0000000000002191","article-title":"The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation","volume":"102","author":"Kotton","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.antiviral.2020.104711_bib61","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.1128\/JVI.72.6.4721-4728.1998","article-title":"Resistance of human cytomegalovirus to benzimidazole ribonucleosides maps to two open reading frames: UL89 and UL56","volume":"72","author":"Krosky","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104711_bib62","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1128\/JVI.77.2.905-914.2003","article-title":"The human cytomegalovirus UL97 protein kinase, an antiviral drug target, is required at the stage of nuclear egress","volume":"77","author":"Krosky","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104711_bib63","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1128\/AAC.44.3.688-692.2000","article-title":"A standardized plaque reduction assay for determination of drug susceptibilities of cytomegalovirus clinical isolates","volume":"44","author":"Landry","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104711_bib64","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1128\/AAC.01596-09","article-title":"In vitro and in vivo activities of the novel anticytomegalovirus compound AIC246","volume":"54","author":"Lischka","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104711_bib65","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/infdis\/jiv352","article-title":"Characterization of cytomegalovirus breakthrough events in a Phase 2 prophylaxis trial of letermovir (AIC246, MK 8228)","volume":"213","author":"Lischka","year":"2016","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104711_bib66","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/358160a0","article-title":"Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir","volume":"358","author":"Littler","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2020.104711_bib67","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1086\/515293","article-title":"Mutations in the cytomegalovirus UL97 gene associated with ganciclovir-resistant retinitis","volume":"177","author":"Liu","year":"1998","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104711_bib68","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0219701","article-title":"Improvement in detecting cytomegalovirus drug resistance mutations in solid organ transplant recipients with suspected resistance using next generation sequencing","volume":"14","author":"Lopez-Aladid","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.antiviral.2020.104711_bib69","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1128\/CMR.00009-10","article-title":"Antiviral drug resistance of human cytomegalovirus","volume":"23","author":"Lurain","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2020.104711_bib70","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMoa1714656","article-title":"Maribavir for preemptive treatment of cytomegalovirus reactivation","volume":"381","author":"Maertens","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2020.104711_bib71","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/B978-0-12-385987-7.00004-X","article-title":"Regulatory roles of protein kinases in cytomegalovirus replication","volume":"80","author":"Marschall","year":"2011","journal-title":"Adv. Virus Res."},{"key":"10.1016\/j.antiviral.2020.104711_bib72","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.jcv.2010.08.008","article-title":"Contrasting effects on ganciclovir susceptibility and replicative capacity of two mutations at codon 466 of the human cytomegalovirus UL97 gene","volume":"49","author":"Martin","year":"2010","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2020.104711_bib73","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1056\/NEJMoa1706640","article-title":"Letermovir prophylaxis for cytomegalovirus in hematopoietic-cell transplantation","volume":"377","author":"Marty","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2020.104711_bib74","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1099\/0022-1317-79-9-2105","article-title":"Functional regions of the human cytomegalovirus protein pUL97 involved in nuclear localization and phosphorylation of ganciclovir and pUL97 itself","volume":"79","author":"Michel","year":"1998","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.antiviral.2020.104711_bib75","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02384-16","article-title":"Mutual interplay between the human cytomegalovirus terminase subunits pUL51, pUL56, and pUL89 promotes terminase complex formation","volume":"91","author":"Neuber","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2020.104711_bib76","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/cid\/ciy706","article-title":"Maribavir for refractory or resistant cytomegalovirus infections in hematopoietic-cell or solid-organ transplant recipients: a randomized, dose-ranging, double-blind, Phase 2 study","volume":"68","author":"Papanicolaou","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104711_bib77","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.antiviral.2014.08.014","article-title":"Human cytomegalovirus (CMV) susceptibility to currently approved antiviral drugs does not impact on CMV terminase complex polymorphism","volume":"111","author":"Pilorge","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104711_bib78","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.antiviral.2019.01.011","article-title":"Clinical development of letermovir and maribavir: overview of human cytomegalovirus drug resistance","volume":"163","author":"Piret","year":"2019","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2020.104711_bib79","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofz375","article-title":"Emergence and persistence of letermovir-resistant cytomegalovirus in a patient with primary immunodeficiency","volume":"6","author":"Popping","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.antiviral.2020.104711_bib80","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/rmv.615","article-title":"Function of human cytomegalovirus UL97 kinase in viral infection and its inhibition by maribavir","volume":"19","author":"Prichard","year":"2009","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.antiviral.2020.104711_bib81","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1128\/JCM.01605-13","article-title":"Detection of cytomegalovirus drug resistance mutations by next-generation sequencing","volume":"51","author":"Sahoo","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2020.104711_bib82","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.1128\/AAC.00802-10","article-title":"Improved detection of mutated human cytomegalovirus UL97 by pyrosequencing","volume":"54","author":"Schindele","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104711_bib83","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/1471-2334-13-330","article-title":"Fast selection of maribavir resistant cytomegalovirus in a bone marrow transplant recipient","volume":"13","author":"Schubert","year":"2013","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104711_bib84","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1128\/AAC.00633-06","article-title":"Multidrug resistance conferred by novel DNA polymerase mutations in human cytomegalovirus isolates","volume":"51","author":"Scott","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104711_bib85","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1086\/514041","article-title":"High-level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and DNA polymerase genes","volume":"176","author":"Smith","year":"1997","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104711_bib86","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.3390\/ijms12053191","article-title":"KRAS mutation detection in paired frozen and Formalin-Fixed Paraffin-Embedded (FFPE) colorectal cancer tissues","volume":"12","author":"Solassol","year":"2011","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.antiviral.2020.104711_bib87","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1128\/AAC.35.11.2191","article-title":"Ganciclovir-resistant cytomegalovirus clinical isolates: mode of resistance to ganciclovir","volume":"35","author":"Stanat","year":"1991","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104711_bib88","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1086\/653122","article-title":"Virologic characterization of multi-drug-resistant cytomegalovirus infection in two transplant recipients treated with maribavir","volume":"202","author":"Strasfeld","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2020.104711_bib89","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/358162a0","article-title":"A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells","volume":"358","author":"Sullivan","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2020.104711_bib90","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02337-18","article-title":"Use of letermovir as salvage therapy for drug-resistant cytomegalovirus retinitis","volume":"63","author":"Turner","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104711_bib91","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1128\/AAC.48.5.1647-1651.2004","article-title":"Mechanism of action of the ribopyranoside benzimidazole GW275175X against human cytomegalovirus","volume":"48","author":"Underwood","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2020.104711_bib92","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1073\/pnas.98.4.1895","article-title":"Distinct and separate roles for herpesvirus-conserved UL97 kinase in cytomegalovirus DNA synthesis and encapsidation","volume":"98","author":"Wolf","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219306758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219306758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:32:30Z","timestamp":1759062750000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354219306758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":92,"alternative-id":["S0166354219306758"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104711","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances in the genotypic diagnosis of cytomegalovirus antiviral drug resistance","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2020.104711","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104711"}}